Creatine for Cognitive Health: Does the Brain Evidence Hold Up?

Creatine monohydrate has one of the most thoroughly validated evidence bases in sports nutrition: decades of research consistently support its role in increasing phosphocreatine stores in skeletal muscle, improving performance in high-intensity, short-duration exercise, and augmenting strength and lean mass gains from resistance training. The International Society of Sports Nutrition has classified creatine monohydrate as the most effective ergogenic nutritional supplement available for increasing high-intensity exercise capacity and lean body mass.

In recent years, the marketing narrative around creatine has expanded significantly into cognitive health. Products now position creatine as a "brain fuel" supplement, claiming improvements in memory, processing speed, mental fatigue resistance, and protection against cognitive decline. The cognitive claims are not without biological basis — the brain uses the phosphocreatine system for rapid ATP regeneration, and brain creatine levels are measurably elevated by oral supplementation. But the translation from elevated brain creatine to clinically meaningful cognitive improvement in healthy adults is more conditional than the marketing implies, and the populations most likely to benefit are specific and often not the ones being targeted.

This analysis focuses on the cognitive evidence, examines which populations the data actually support, and identifies where the brain-health marketing claims outrun the trial literature.

The Biological Basis: Brain Creatine and the Phosphocreatine System

The brain is metabolically demanding, consuming approximately 20% of the body's total energy despite representing only 2% of body weight. Neurons rely heavily on oxidative phosphorylation for sustained ATP production, but rapid fluctuations in energy demand — during intense cognitive tasks, sleep deprivation, or hypoxic stress — require a faster energy buffer. The phosphocreatine (PCr) system provides this: creatine kinase catalyzes the rapid transfer of a phosphate group from PCr to ADP, regenerating ATP within milliseconds.

Creatine is synthesized endogenously in the liver and kidneys from arginine and glycine, and is also obtained from dietary sources (primarily red meat and fish). Vegetarians and vegans have substantially lower baseline muscle and brain creatine stores than omnivores, which has important implications for who is most likely to respond to supplementation. Oral creatine monohydrate supplementation raises brain creatine concentrations measurably: phosphorus magnetic resonance spectroscopy (31P-MRS) studies have confirmed 5–15% increases in brain phosphocreatine following supplementation protocols of 20 g/day for 5–7 days or 3–5 g/day for 4–6 weeks.

The mechanistic case for cognitive benefit is therefore not implausible. The question is whether the modest increases in brain creatine achievable through supplementation produce detectable cognitive improvements in individuals who are not creatine-depleted, sleep-deprived, or under metabolic stress.

The Cognitive Evidence: Where It Is Strongest

The most consistent cognitive findings for creatine come from three specific contexts: vegetarians/vegans, sleep-deprived individuals, and older adults. These are the populations where baseline brain creatine is most likely to be suboptimal, and where the supplementation effect is largest.

Rae and colleagues (2003, Proceedings of the Royal Society B) conducted a double-blind crossover RCT in 45 young adult vegetarians, randomizing them to creatine (5 g/day) or placebo for 6 weeks. The creatine group showed significant improvements on two cognitive tests: backward digit span (working memory) and Raven's Progressive Matrices (fluid intelligence). The effect sizes were meaningful, and the vegetarian population is the most biologically plausible responder given their lower baseline creatine stores. This remains one of the most cited and methodologically credible trials in the creatine cognition literature.

McMorris and colleagues (2006, 2007, Physiology & Behavior) examined creatine supplementation under sleep deprivation conditions. In sleep-deprived subjects (24 hours without sleep), creatine supplementation (20 g/day for 7 days) significantly attenuated the decline in random movement generation and choice reaction time compared to placebo. The interpretation is that creatine's energy buffer is most relevant when the brain is under metabolic stress from sleep deprivation, where PCr demand is elevated.

In older adults, Rawson and Venezia (2011, Sub-Cellular Biochemistry) reviewed the available evidence and concluded that creatine supplementation produces modest but consistent improvements in cognitive tasks in older populations, particularly those involving working memory and processing speed. The effect is plausibly related to age-associated declines in brain creatine synthesis and mitochondrial function.

The Cognitive Evidence: Where It Is Weakest

The evidence for cognitive enhancement in healthy, well-nourished, omnivorous, non-sleep-deprived young adults is considerably weaker. Rawson and colleagues (2008, Amino Acids) found no significant effect of creatine supplementation on cognitive performance in young omnivorous adults under normal conditions. A 2022 meta-analysis by Avgerinos and colleagues (Experimental Gerontology) pooled six RCTs and found a significant overall effect of creatine on memory, but the effect was driven primarily by older adults and vegetarians; the effect in young omnivores was not significant.

This pattern is consistent with the underlying biology: if brain creatine is already at or near saturation in a well-nourished omnivore, additional supplementation produces a smaller incremental increase, and the cognitive benefit of that increment is correspondingly smaller. The "brain fuel" marketing that targets healthy young adults as the primary audience is therefore targeting the population least likely to see meaningful cognitive benefit.

What the Evidence Actually Shows

"Clinically proven to enhance memory" is selectively true. The strongest memory evidence comes from vegetarians (Rae et al. 2003) and older adults — populations with lower baseline creatine stores. The evidence in healthy young omnivores under normal conditions is not significant in the best-powered analyses. Applying the vegetarian or older-adult trial results to a general young adult audience is an extrapolation the data do not support.

"Sharpen focus" is not well-supported by the creatine literature specifically. The sleep-deprivation studies show attenuation of cognitive decline under stress, not enhancement above baseline in rested individuals. These are different claims.

"Your brain runs on creatine too" is mechanistically accurate. The phosphocreatine system is genuinely important for brain energy metabolism. The marketing correctly identifies a real biological mechanism; it then overapplies the evidence from specific populations to a general audience.

Key Trials in the Creatine Cognition Literature

Verdict & Clinical Implications

For consumers, the practical implication is that creatine monohydrate (3–5 g/day) is a reasonable supplement for vegetarians, vegans, older adults, and anyone with high cognitive demands under sleep restriction or physical stress. For healthy young omnivores seeking cognitive enhancement under normal conditions, the expected benefit is modest and the evidence is weaker. The athletic evidence remains the strongest reason to take creatine; the cognitive benefit, where it exists, is a secondary effect in specific populations rather than a primary indication for the general market.